XP13512 (Gabapentin Enacarbil)

gabapentin enacarbil · XenoPort, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XP13512 (Gabapentin Enacarbil), covering 2011-06-23 to 2011-06-23. Get the full timeline:

Most recent: Clinical Trial Update: XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome. [Phase 3]